Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
4.640
+1.180 (34.10%)
At close: Dec 20, 2024, 4:00 PM
4.750
+0.110 (2.37%)
After-hours: Dec 20, 2024, 7:59 PM EST
Humacyte Market Cap
Humacyte has a market cap or net worth of $597.02 million as of December 20, 2024. Its market cap has increased by 104.40% in one year.
Market Cap
597.02M
Enterprise Value
656.09M
1-Year Change
104.40%
Ranking
Category
Stock Price
$4.64
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $597.02M, an increase of 380.28%. That is a compound annual growth rate of 47.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 597.02M | 102.96% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 457.20M |
| UroGen Pharma | 456.60M |
| Zevra Therapeutics | 456.36M |
| Ginkgo Bioworks Holdings | 450.14M |
| ProKidney | 446.24M |
| Celcuity | 442.58M |
| DocGo | 439.84M |
| Emergent BioSolutions | 438.35M |